| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc | SVP Regulatory Affairs | Ordinary Shares | 62,625 | $507,432 | $8.10 | 01 Feb 2024 | Direct |
| Centessa Pharmaceuticals plc | SVP Regulatory Affairs | Share Option (right to buy) | 75,000 | 01 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals plc | 01 Feb 2024 | 4 | -$68,219 | 4 | SVP Regulatory Affairs | 02 Feb 2024, 17:03 |
| CNTA | Centessa Pharmaceuticals plc | 20 Sep 2023 | 5 | -$72,000 | 4 | SVP Regulatory Affairs | 22 Sep 2023, 16:47 |
| CNTA | Centessa Pharmaceuticals plc | 14 Jun 2023 | 0 | $0 | 3 | SVP Regulatory Affairs | 23 Jun 2023, 17:01 |